HIV molecular immunology database

 

Patient Detail

Patient Code Donor N152
Patient Sex Male
Risk Factor
Infection Country
Infection City
Infection Year
HLA Type
Patient Ethnicity
Progression Slow progressor (SP)
Species human
Patient Note At time of leukapheresis for MAb 10E8, patient had been infected with HIV-1 for 20 years; infected with clade B; selected because his serum neutralizing activity was among the most potent and broad in the cohort.
CTL CD8+ Records
T-Helper CD4+ Records
Antibody Records 10E8 (2708), 7H6 (2709), 10E8-19fH/16fL (3072), 10E8-19fH/10fL (3073), 10E8-10fH/16fL (3074), 10E8-10fH/10fL (3075), 10E8-10fH/4fL (3076), 10E8-2fH/10fL (3077), 10E8-2fH/4fL (3078), 10E8-0fH/4fL (3079), 10E8-0fH/0fL (3080), 10E8-2fH/0fL (3081), 35O22 (3147), 7B9 (3148), 4O20 (3149), 10J4 (3150), 7K3 (3151), 13I10 (3152), 2N5 (3153), 10M6 (3154), 10E8V1.1/P140 (3471), 10E8V2.0/iMab (3472), 3BNC117/10E8 (3477), 10E8v4 (3508), PGT151/35O22 (3518), 8ANC195/10E8 (3527), polyclonal N152 (3900), VRC01/PGDM1400-10E8v4 (3955), N6/PGDM1400-10E8v4 (3956), N6/10E8v4-PGDM1400 (3957), Tri-NAb (3959), 10E8/N6 (3978), 10E8/PGT121/PGDM1400.V1 (3981), 10E8/PGT121/PGDM1400.V2 (3982), 10E8/PGT121/PGDM1400.V4 (3983), 10E8/PGT121/PGDM1400.V3 (3984), 10E8/PGT121/PGDM1400.V5 (3985), 10E8/PGT121/PGDM1400.V6 (3986), 10E8/PGT121/PGDM1400.V7 (3987), 10E8/PGT121/PGDM1400.V8 (3988), 10E8/PGT121/PGDM1400.V8Fc (3989), 10E8/PGT121/PGDM1400.V8LL (3990), 10E8/PGT121/PGDM1400.V8.4DS (3991), 10E8/PGDM1400/PRO-140 (3992), 10E8v4-5R-100cF (4002), 10E8 IgG mutant 1 (4018), 10E8 IgG mutant 2 (4019), 10E8 IgG mutant 3 (4020), 10E8 IgG mutant 4 (4021), 10E8 IgG mutant 5 (4022), 10E8.4/iMab (4167)
Sequence Database Patient ID Record 75177
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health